Table 1 Patient characteristics.

From: A scoring system based on inflammatory and nutritional indicators to predict the long-term survival of patients with non-metastatic nasopharyngeal carcinoma

Characteristics

Total (N = 1024)

Training group (N = 675)

Validation group (N = 349)

P value

Age (year)

 < 60

878(85.74%)

582 (86.22%)

296 (84.81%)

 

 ≥ 60

146(14.26%)

93 (13.78%)

53 (15.19%)

0.532

Sex

 Male

890 (86.91%)

585 (86.67%)

305 (87.39%)

0.304

 Female

134 (13.09%)

90 (13.33%)

44 (12.61%)

Histology

 WHO I

28 (2.73%)

17 (2.52%)

11 (3.15%)

0.364

 WHO II

105 (10.25%)

69 (10.22%)

36 (10.31%)

 WHO III

877 (85.65%)

579 (85.78%)

298 (85.39%)

 Other

14 (1.37%)

10 (1.48%)

4 (1.15%)

T category

 1

194 (18.95%)

122 (18.08%)

72 (20.63%)

0.575

 2

250 (24.41%)

165 (24.44%)

85 (24.36%)

 3

320 (31.25%)

223 (33.04%)

97 (27.79%)

 4

260 (25.39%)

165 (24.44%)

95 (27.22%)

N category

 0

82 (8.01%)

47 (6.96%)

35 (10.03%)

0.794

 1

198 (19.34%)

129 (19.11%)

69 (19.77%)

 2

579 (56.54%)

385 (57.04%)

194 (55.59%)

 3

165 (16.11%)

114 (16.89%)

51 (14.61%)

Stage

 I

26 (2.54%)

16 (2.37%)

10 (2.87%)

0.774

 II

73 (7.13%)

50 (7.41%)

23 (6.59%)

 III

535 (52.25%)

352 (52.15%)

183 (52.43%)

 IV

390 (38.08%)

257 (38.07%)

133 (38.11%)

WBC

 < 6.3 (× 10^9/L)

371 (36.2%)

244 (36.1%)

127 (36.4%)

0.879

 ≥ 6.3 (× 10^9/L)

653 (63.8%)

431 (63.9%)

222 (63.6%)

N

 < 2.1 (× 10^9/L)

24 (2.3%)

18 (2.7%)

6 (1.7%)

0.057

 ≥ 2.1 (× 10^9/L)

1000 (97.7%)

657 (97.3%)

343 (98.3%)

L

 < 2.3 (× 10^9/L)

11 (1.1%)

6 (0.9%)

5 (1.4%)

0.11

 ≥ 2.3 (× 10^9/L)

1013 (98.9%)

669 (99.1%)

344 (98.6%)

M

 < 0.49 (× 10^9/L)

437 (42.7%)

300 (44.4%)

137 (39.3%)

0.051

 ≥ 0.49 (× 10^9/L)

587 (57.3%)

375 (55.6%)

212 (60.7%)

PLT

 < 136 (× 10^9/L)

957 (93.5%)

630 (93.3%)

327 (93.7%)

0.198

 ≥ 136 (× 10^9/L)

67 (6.5%)

45 (6.7%)

22 (6.3%)

HB

 < 111 (g/L)

38 (3.7%)

24 (3.6%)

14 (4.0%)

0.533

 ≥ 111 (g/L)

986 (96.3%)

651 (96.4%)

335 (96.0%)

ALB

 < 39.7 (g/L)

295 (28.8%)

195 (28.9%)

100 (28.7%)

0.875

 ≥ 39.7 (g/L)

729 (71.2%)

480 (71.1%)

249 (71.3%)

NLR

 < 2.21

580 (56.6%)

387 (57.3%)

193 (55.3%)

0.242

 ≥ 2.21

444 (43.4%)

288 (42.7%)

156 (44.7%)

PLR

 < 226.15

896 (87.5%)

595 (88.%1)

301 (86.2%)

0.084

 ≥ 226.15

128 (12.5%)

80 (11.9%)

48 (13.8%)

SII

 < 1040

942 (92.0%)

621 (92.0%)

321 (92.0%)

0.98

 ≥ 1040

82 (8.0%)

54 (8.0%)

28 (8.0%)

SIRI

 < 1.2

647 (63.2%)

426 (63.1%)

221 (63.3%)

0.068

 ≥ 1.2

377 (36.8%)

249 (36.9%)

128 (36.7%)

BMI

 < 21.7

409 (39.9%)

266 (39.4%)

143 (41.0%)

0.346

 ≥ 21.7

615 (60.1%)

409 (60.6%)

206 (59.0%)

PNI

 < 56.9

919 (89.7%)

616 (91.3%)

303 (86.8%)

0.666

 ≥ 56.9

105 (10.3%)

59 (8.7%)

46 (13.2%)

NRI

  < 105.3

909 (88.8%)

587 (87.0%)

322 (92.3%)

0.456

 ≥ 105.3

115 (11.2%)

88 (13.0%)

27 (7.7%)

PAR

 < 3.58

956 (93.4%)

632 (93.6%)

324 (92.8%)

0.336

 ≥ 3.58

68 (6.6%)

43 (6.4%)

25 (7.2%)